Athithi Verma
DealFlow H1 2026 Review: M&A Rebounds as Upfront Deal Spending Doubles Synopulse · DealFlow · Healthcare & life sciences dealmaking · H1 2026 review M&A came back big, and wrote the cheque in cash M&A value rose 96% to $188 billion in the first half of 2026 and upfront payments jumped 72%, as acquirers paid … Read more
Germany’s lawmakers had no shortage of warnings. Drugmakers objected. Trade groups objected. So did opposition voices inside the country’s own government. The reform passed anyway. Late on Friday, the Bundestag, Germany’s lower house of parliament, approved a health insurance financial reform package by 318 votes to 284, with four abstentions. That is not a comfortable … Read more
The FTC has settled its insulin pricing case against Caremark, the CVS-owned pharmacy benefit manager, claiming up to $13 billion in patient savings over the next decade.
The Pulse – Weekly biopharma intelligence – Synopulse Synopulse The Pulse Synopulse’s weekly biopharma briefing – deals, approvals, readouts and access, across every therapy area. WEEKLY6 – 12 July 2026Wk 28 · 2026 The Hub Neurology19 Onco+Immuno30 CardioMeta17 Approvals The big events this week Deal Vertex acquires Crinetics for $10 billion The week’s largest transaction … Read more
Women in the UK wait more than nine years, on average, to be told they have endometriosis. A new pair of tests could start to close that gap and do it without surgery. On 7 July, the National Institute for Health and Care Excellence (NICE) published draft guidance recommending that two non-invasive diagnostic tests, Endotest … Read more
AlzeCure Pharma has found a partner for its Alzheimer’s program, and the numbers attached to the deal are eye-catching, though not all of them in the way the headline suggests. The Swedish biotech said on July 1 that it has signed an out-licensing and collaboration agreement with QuantumCell, a Danish “tech-enabled” biotech, handing over global … Read more
Boulevard Bio is paying $20 million upfront and committing up to $1.6 billion in milestones for the global rights to MTS-128, a trispecific T-cell engager.
NeuroPulse — Wk 26 · 2026 · Synopulse NeuroPulseDeep pine banner. An indigo neural network of neurons and synapses fills the right side, with a gold signal pulse firing along a chain of neurons, beside the NeuroPulse wordmark under the Synopulse and The Pulse kicker. Synopulse · The Pulse NeuroPulse This week in neuroscience Week … Read more
The rules of pharmaceutical market access are being rewritten. From IRA-mandated price ceilings to AI-driven outcomes contracting.
Pfizer has signed one of the year’s largest cross-Pacific oncology deals, pledging $650 million upfront and up to $9.85 billion in milestones to co-develop 12 early-stage cancer assets with China’s Innovent Biologics.